← Back

Repaglinide

Tablet0.5mg · 1mg · 2mg76 brands · 30 makers
Repaglinide is a medicine listed in the NepalDoc medicine catalog. According to its FDA label, it is tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 76 brand names for this medicine are listed in the NepalDoc medicine catalog.
Generic namerepaglinide
Form & strengthCatalog forms: Tablet · Catalog strengths: 0.5mg, 1mg, 2mg
Source / स्रोतNepalDoc medicine catalog

What it's for

Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

From the U.S. FDA-approved label for Repaglinide. Full label: DailyMed.

Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

From the U.S. FDA-approved label for Repaglinide. Full label: DailyMed.

The recommended starting dose is 0.5 mg orally before each meal if HbA1c is less than 8%; and 1 or 2 mg orally before each meal if HbA1c is 8% or greater. The recommended dose range is 0.5 mg to 4 mg before meals, with a maximum daily dose of 16 mg. The patient’s dose should be doubled up to 4 mg with each meal until satisfactory glycemic control is achieved.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Repaglinide tablets are contraindicated in patients with: Concomitant use of gemfibrozil Known hypersensitivity to repaglinide or any inactive ingredients Concomitant use with gemfibrozil Known hypersensitivity to repaglinide or any inactive ingredients

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Hypoglycemia: Repaglinide may cause hypoglycemia. Skip the scheduled dose of repaglinide if a meal is skipped to reduce the risk of hypoglycemia. Reduce the dose of repaglinide if hypoglycemia occurs. Serious Cardiovascular Adverse Reactions with Concomitant NPH-insulin: Repaglinide is not indicated for use in combination with NPH-insulin. Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with repaglinide. 5.1 Hypoglycemia All glinides, including repaglinide, can cause hypoglycemia.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reaction is also described elsewhere in the labeling: Hypoglycemia The most common adverse reactions (5% or greater incidence) among patients treated with repaglinide were: hypoglycemia, upper respiratory infection, headache, sinusitis, arthralgia, nausea, diarrhea, and back pain. To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

76 products from 30 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Eurepa 0.5mg TabletRepaglinide (0.5mg)Torrent Pharmaceuticals Ltd.
Eurepa 1mg TabletRepaglinide (1mg)Torrent Pharmaceuticals Ltd.
Eurepa 2mg TabletRepaglinide (2mg)Torrent Pharmaceuticals Ltd.
Novonorm 0.5 TabletRepaglinideNovartis India Ltd.
Novonorm 1 TabletRepaglinideNovartis India Ltd.
Novonorm 2 TabletRepaglinideNovartis India Ltd.
Premil 0.5mg TabletRepaglinide (0.5mg)Beximco Pharmaceuticals Ltd.
Premil 1mg TabletRepaglinide (1mg)Beximco Pharmaceuticals Ltd.
Premil 2mg TabletRepaglinide (2mg)Beximco Pharmaceuticals Ltd.
Repanide 0.5mg TabletRepaglinide (0.5mg)Quest Pharmaceuticals Pvt. Ltd.
Repanide 1mg TabletRepaglinide (1mg)Quest Pharmaceuticals Pvt. Ltd.
Repanide 2mg TabletRepaglinide (2mg)Quest Pharmaceuticals Pvt. Ltd.
Benzorepa 1mg TabletRepaglinide (1mg)Ranmarc Labsstrip of 10 tablets
Eurepa 0.5 TabletRepaglinide (0.5mg)Torrent Pharmaceuticals Ltdstrip of 15 tablets
Eurepa 1 TabletRepaglinide (1mg)Torrent Pharmaceuticals Ltdstrip of 15 tablets
Eurepa 2 TabletRepaglinide (2mg)Torrent Pharmaceuticals Ltdstrip of 15 tablets
Genericart Repaglinide 1mg TabletRepaglinide (1mg)Swast Aushadhi Seva Generic Medicine Storestrip of 10 tablets
Hirepa 0.5mg TabletRepaglinide (0.5mg)Healing Pharma India Pvt Ltdstrip of 10 tablets
Hirepa 1mg TabletRepaglinide (1mg)Healing Pharma India Pvt Ltdstrip of 10 tablets
Hirepa 2mg TabletRepaglinide (2mg)Healing Pharma India Pvt Ltdstrip of 10 tablets
Lunch ON 0.5mg TabletRepaglinide (0.5mg)Icon Life Sciencesstrip of 10 tablets
Lunch ON 1mg TabletRepaglinide (1mg)Illumin Pharmastrip of 10 tablets
Lunch ON 2mg TabletRepaglinide (2mg)Icon Life Sciencesstrip of 10 tablets
Mage 0.5mg TabletRepaglinide (0.5mg)Eris Lifesciences Ltdstrip of 10 tablets
Mage 1mg TabletRepaglinide (1mg)Eris Lifesciences Ltdstrip of 10 tablets
Mage 2mg TabletRepaglinide (2mg)Eris Lifesciences Ltdstrip of 10 tablets
Novonorm 0.5mg TabletRepaglinide (0.5mg)Novo Nordisk India Pvt Ltdstrip of 15 tablets
Novonorm 1mg TabletRepaglinide (1mg)Novo Nordisk India Pvt Ltdstrip of 15 tablets
Novonorm 2mg TabletRepaglinide (2mg)Novo Nordisk India Pvt Ltdstrip of 15 tablets
Page 0.5mg TabletRepaglinide (0.5mg)Orchid Chemicals & Pharmaceuticals Ltdstrip of 10 tablets

Showing 30 of 76 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store at 20° to 25°C (68° to 77°F). Protect from moisture. Keep bottles tightly closed.

Storage information from the U.S. FDA-approved label.

Medicines for the same conditions

Repaglinide is recorded in the NepalDoc medicine catalog for: Type 2 DM.

For Type 2 DM: Acarbose, Glibenclamide, Gliclazide, Glimepiride, Glipizide, Metformin.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.